Challenges in Drug Development for Special Populations
This meeting is designed to address the challenges, both statistical and
medical, faced when developing drugs for special populations. There is great
diversity in the human population, and, in order to provide safe and
efficacious treatments, it is necessary to consider their particular
conditions and medical needs
17th May 2005
Venue
Browns Courtrooms
82 - 84 St Martins Lane
Covent Garden
London
WC2N 4AA
Speakers from industry, academia and the UK regulatory agency
09.00 - 09.30 Registration
09.30 - 10.10 Dealing with Population Diversity in Pharmacogenomic Studies
10.10 - 10.50 Standards for Studies of Rare Diseases
10.50 - 11.20 Coffee
11.20 - 12.00 Japan - A Bridge Too Far?
12.00 - 12.40 Bridging Between Japanese and Caucasian Populations Using
Pharmacokinetic Data
12.40 - 14:00 Lunch
14:00 - 14:40 Renal Disease, Drug Dosage and Safety
14:40 - 15:20 Medicines for Children - issues and examples from HIV
infected children
15:20 - 15:50 Tea
15:50 - 16:30 Clinical and Statistical Issues Arising from Working with
Diseases of the Developing World
Registration Costs
Fee includes lunch & refreshments
PSI Members £160.00 (plus VAT)
Non-Members £175 (plus VAT)
Contact
Alison Houghton
Tel: +44 (0)1625 267880 ext 228
Fax: +44 (0)1625 267879
[log in to unmask]
PSI Executive Office
Resources for Associations
South Park Road, Macclesfield
SK11 6SH, UK
On line registration and Payment is now possible using Credit Card via the
Website: www.psiweb.org
|